South Africa needs to adapt its HIV prevention and treatment programs to better meet the needs of an older population.
Launched in 2021, CAUSALab brings together 14 epidemiology faculty members across multiple universities to collaborate on applying causal inference methods to compare the effectiveness and safety of health and policy interventions in a broad range of areas.
When the lab of the Botswana Harvard AIDS Institute Partnership produced the first genetic sequence of the Omicron variant of the coronavirus in fall 2021, the world took notice. More recognition came last month when the lab was…
Roger Shapiro, professor of immunology and infectious diseases, discusses his recent study of a new treatment option for children living with HIV.
Katherine Tassiopoulos, senior research scientist in the Department of Epidemiology, explains the findings of a recent study on social support and viral suppression among young adults living with HIV.
Members of the Department of Biostatistics recently gathered for a symposium celebrating the 50-year career of Victor De Gruttola, former chair and professor of biostatistics emeritus.
During pregnancy, the timing of when mothers start taking antiretroviral drugs to treat HIV may impact the risk of developmental delays in children, according to a study co-authored by researchers at Harvard Chan School.
Octavious Smiley, PhD ’23, is dedicated to helping the next generation of minority students excel in the field of biostatistics.
PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.
Researchers at Harvard Chan School have developed a new, highly adaptable vaccine platform that could potentially be a powerful tool in the fight against viral pathogens including influenza, HIV, and SARS-CoV-2.